Theralase Technologies Inc. V.TLT

New Press Release - Theralase(R) to Host Advisory Board Meetings at Canadian Urological Association Bladder Cancer Forum and the American Urological Association

TORONTO, ON / ACCESSWIRE / March 26, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds ("PDCs") and their associated drug...read article.

[made2last]

Hi all; I like the statement. "Arkady Mandel MD, PhD, DSc, Chief Scientific Officer of Theralase® stated, "Patients with BCG-Unresponsive NMIBC CIS have limited treatment options other than bladder removal surgery. We look forward to discussing the STRONG, INTERIM CLINICAL DATA from Study II with the PIs of the study, who are key opinion leaders in the Canadian and US

[Legit62]

Like the comment but need BTD sooner than later as stated in previous NRs

[StevenBirch]

Some noted that the number of treated patients hasn't changed from 63, thinking maybe it was beneficial to ramp up enrollment after BTD, hopefully they could get BTD before hosting these meetings? If that were to happen everything would be falling into place.

[toade1313]

DISAPPOINTED!!!  It's what was not mentioned in this press release. 1. No update on current number treated. 2. No mention of filing pre BTD in 1st quarter. 3. No confirming of filing final BTD in 2nd quarter. 4. No good surprise news on other items. Guess the next PR will be later this week announcing the next PP. 

[StevenBirch]

With all due respect Toade are you ever not disappointed? This doesn't seem like 'that' news release. I would expect that info when they announce they have closed this latest PP, which I wish they didn't have to do either by the way but it is what it is.

[Alamir1111]

An advisory board meeting is scheduled to take place on April 12, 2024, during the Bladder Cancer Forum 2024 located in Toronto, Ontario to provide an update to all Canadian Principal Investigators ("PIs") of the Study II interim clinical data and to discuss opportunities for patient enrollment. What is an advisory committee? Advisory committees provide independent expert advice to

[Alamir1111]

If the Principal investigators get exited much as us  about presented data it should help recruitment